跳至主要内容
临床试验/JPRN-UMIN000001614
JPRN-UMIN000001614已完成2 期

Multicenter phase II study of second-line S-1 monotherapy in patients with gemcitabine-refractory advanced biliary tract cancer - Phase II study of S-1 monotherapy in patients with gemcitabine-refractory advanced biliary tract cancer

Faculty of Medicine, University of Tokyo0 个研究点目标入组 22 人开始时间: 2009年1月3日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with an active concomitant infection 2) Patients with digestive ulcer or gastrointestinal bleeding 3) Patients with severe cardiovascular or renal disease 4) Patients with uncontrollable massive pleural effusion or massive ascites 5) Patients with an active concomitant malignancy 6) Pregnant, lactating female and patients of reproductive potential who did not use effective contraception 7) Patients with a previous history of a severe drug hypersensitivity 8) Patients receiving anti-cancer drugs 9) Inappropriate patients for entry on this study in the judgement of the investigator

研究者

发起方
Faculty of Medicine, University of Tokyo

相似试验